$MMSI
MERIT MEDICAL SYSTEMS INC Stock $mmsi

$mmsi Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-Q Financial Statement

#000085698219000049 Filed on May 03, 2019

Income Statement

Concept	2019 Q1	2018 Q1
Revenue	$238.3M	$203.0M
YoY Change	17.39%	18.69%
Cost Of Revenue	$133.7M	$115.0M
YoY Change	16.29%	20.87%
Gross Profit	$104.6M	$88.06M
YoY Change	18.83%	15.95%
Gross Profit Margin	43.9%	43.37%
Selling, General & Admin	$78.27M	$64.91M
YoY Change	20.58%	12.36%
% of Gross Profit	74.8%	73.72%
Research & Development	$16.04M	$14.32M
YoY Change	12.02%	14.35%
% of Gross Profit	15.33%	16.26%
Depreciation & Amortization	$22.35M	$15.28M
YoY Change	46.22%	19.79%
% of Gross Profit	21.36%	17.36%
Operating Expenses	$95.11M	$79.28M
YoY Change	19.98%	12.71%
Operating Profit	$9.523M	$8.781M
YoY Change	8.45%	56.55%
Interest Expense	$2.764M	$2.398M
YoY Change	15.26%	-11.38%
% of Operating Profit	29.02%	27.31%
Other Income/Expense, Net	-$2.677M	-$2.422M
YoY Change	10.53%	-124.5%
Pretax Income	$6.846M	$6.359M
YoY Change	7.66%	-58.96%
Income Tax	$651.0K	$1.090M
% Of Pretax Income	9.51%	17.14%
Net Earnings	$6.195M	$5.269M
YoY Change	17.57%	-64.41%
Net Earnings / Revenue	2.6%	2.6%
Basic Earnings Per Share	$0.11	$0.10
Diluted Earnings Per Share	$0.11	$0.10
COMMON SHARES
Basic Shares Outstanding	54.92M	50.28M shares
Diluted Shares Outstanding	56.49M	51.91M shares

Balance Sheet

Concept	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$49.50M	$34.20M
YoY Change	44.74%	29.06%
Cash & Equivalents	$49.52M	$34.17M
Short-Term Investments
Other Short-Term Assets	$14.80M	$13.70M
YoY Change	8.03%	31.73%
Inventory	$198.9M	$166.7M
Prepaid Expenses
Receivables	$146.5M	$119.1M
Other Receivables	$12.00M	$10.10M
Total Short-Term Assets	$421.8M	$343.8M
YoY Change	22.69%	26.32%
LONG-TERM ASSETS
Property, Plant & Equipment	$340.8M	$303.7M
YoY Change	12.19%	7.18%
Goodwill	$335.0M	$244.1M
YoY Change	37.2%	11.01%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$60.05M	$37.27M
YoY Change	61.12%	28.09%
Total Long-Term Assets	$1.268B	$895.4M
YoY Change	41.61%	20.51%
TOTAL ASSETS
Total Short-Term Assets	$421.8M	$343.8M
Total Long-Term Assets	$1.268B	$895.4M
Total Assets	$1.690B	$1.239B
YoY Change	36.36%	22.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$51.70M	$43.70M
YoY Change	18.31%	34.05%
Accrued Expenses	$91.31M	$57.53M
YoY Change	58.71%	8.81%
Deferred Revenue
YoY Change
Short-Term Debt	$7.000M	$7.000M
YoY Change	0.0%	0.0%
Long-Term Debt Due	$22.00M	$20.73M
YoY Change	6.11%	21.97%
Total Short-Term Liabilities	$178.5M	$124.4M
YoY Change	43.46%	18.37%
LONG-TERM LIABILITIES
Long-Term Debt	$362.2M	$365.8M
YoY Change	-0.99%	65.96%
Other Long-Term Liabilities	$62.36M	$16.03M
YoY Change	289.07%	255.76%
Total Long-Term Liabilities	$424.5M	$381.8M
YoY Change	11.19%	69.77%
TOTAL LIABILITIES
Total Short-Term Liabilities	$178.5M	$124.4M
Total Long-Term Liabilities	$424.5M	$381.8M
Total Liabilities	$749.7M	$550.7M
YoY Change	36.13%	51.77%
SHAREHOLDERS EQUITY
Retained Earnings	$369.7M	$326.7M
YoY Change	13.17%	5.83%
Common Stock	$574.9M	$356.2M
YoY Change	61.4%	3.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$940.1M	$688.5M
YoY Change
Total Liabilities & Shareholders Equity	$1.690B	$1.239B
YoY Change	36.36%	22.07%

Cashflow Statement

Concept	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	$6.195M	$5.269M
YoY Change	17.57%	-64.41%
Depreciation, Depletion And Amortization	$22.35M	$15.28M
YoY Change	46.22%	19.79%
Cash From Operating Activities	$13.51M	$7.935M
YoY Change	70.2%	-47.72%
INVESTING ACTIVITIES
Capital Expenditures	$18.26M	$16.24M
YoY Change	12.41%	59.55%
Acquisitions	$1.942M	$100.2M
YoY Change	-98.06%	111.11%
Other Investing Activities	-$1.900M	-$100.2M
YoY Change	-98.1%	110.95%
Cash From Investing Activities	-$21.05M	-$117.3M
YoY Change	-82.06%	101.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$1.733M	$1.511M
YoY Change	14.69%	-98.89%
Debt Paid & Issued, Net	$54.12M	$149.0M
YoY Change	-63.67%	-12.74%
Cash From Financing Activities	-9.821M	$109.5M
YoY Change	-108.97%	115.88%
NET CHANGE
Cash From Operating Activities	13.51M	$7.935M
Cash From Investing Activities	-21.05M	-$117.3M
Cash From Financing Activities	-9.821M	$109.5M
Net Change In Cash	-17.84M	$1.835M
YoY Change	-1072.04%	-75.84%
FREE CASH FLOW
Cash From Operating Activities	$13.51M	$7.935M
Capital Expenditures	$18.26M	$16.24M
Free Cash Flow	-$4.750M	-$8.304M
YoY Change	-42.8%	-266.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000856982
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	MERIT MEDICAL SYSTEMS INC
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2355000	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2406000	USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54893000	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54995000	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54893000	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54995000	shares
CY2019Q1	us-gaap	Derivative Term Of Contract DerivativeTermOfContract	P2Y
CY2019Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y5M23D
CY2018Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	8300000	USD
CY2018Q1	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	146000	USD
CY2019Q1	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	241000	USD
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	146488000	USD
CY2019Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	55004915	shares
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49522000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67359000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	137174000	USD
CY2019Q1	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	10694000	USD
CY2018Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	11879000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	198922000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	197536000	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11220000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11326000	USD
CY2019Q1	us-gaap	Prepaid Taxes PrepaidTaxes	3620000	USD
CY2018Q4	us-gaap	Prepaid Taxes PrepaidTaxes	3627000	USD
CY2019Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1317000	USD
CY2018Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	933000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	421783000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	429834000	USD
CY2019Q1	us-gaap	Land Land	26764000	USD
CY2018Q4	us-gaap	Land Land	26801000	USD
CY2019Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	152974000	USD
CY2018Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	151251000	USD
CY2019Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	225402000	USD
CY2018Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	221029000	USD
CY2019Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	55378000	USD
CY2018Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	54765000	USD
CY2019Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	34221000	USD
CY2018Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	33678000	USD
CY2019Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	61304000	USD
CY2018Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	53491000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	556043000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	541015000	USD
CY2019Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	215279000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	209563000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	340764000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	331452000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	334951000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	335433000	USD
CY2019Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3083000	USD
CY2018Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3001000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	80453000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	60052000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	57579000	USD
CY2019Q1	mmsi	Intangible Assets Net Goodwill And Other Assets Noncurrent IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent	927246000	USD
CY2018Q4	mmsi	Intangible Assets Net Goodwill And Other Assets Noncurrent IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent	858726000	USD
CY2019Q1	us-gaap	Assets Assets	1689793000	USD
CY2018Q4	us-gaap	Assets Assets	1620012000	USD
CY2019Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	51680000	USD
CY2018Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	54024000	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	91310000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	96173000	USD
CY2019Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	22000000	USD
CY2018Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	22000000	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11825000	USD
CY2019Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1644000	USD
CY2018Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3146000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	178459000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	175343000	USD
CY2019Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	362187000	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	373152000	USD
CY2019Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	56324000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	56363000	USD
CY2019Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	392000	USD
CY2018Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	392000	USD
CY2019Q1	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	3013000	USD
CY2018Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	3013000	USD
CY2019Q1	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	12480000	USD
CY2018Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	11219000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2227000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2261000	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	72243000	USD
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	62357000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	65494000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	749682000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	687237000	USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	574946000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	571383000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	369713000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	363425000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4548000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2033000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	940111000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	932775000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1689793000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1620012000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	238349000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	203035000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	133713000	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	114979000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	104636000	USD
CY2018Q1	us-gaap	Gross Profit GrossProfit	88056000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	78270000	USD
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	64913000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16043000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14322000	USD
CY2019Q1	mmsi	Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit	-775000	USD
CY2018Q1	mmsi	Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit	-40000	USD
CY2019Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	25000	USD
CY2018Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	95113000	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	79275000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	9523000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	8781000	USD
CY2019Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	357000	USD
CY2018Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	146000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	2764000	USD
CY2018Q1	us-gaap	Interest Expense InterestExpense	2398000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-270000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-170000	USD
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2677000	USD
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2422000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	6846000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	6359000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	651000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1090000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	6195000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	5269000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54917000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50277000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56490000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51910000	shares
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	6195000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	5269000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent	-2577000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent	1992000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent	-663000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent	512000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-615000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	2592000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	-14000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	0	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2515000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4072000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	3680000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	9341000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	932775000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	6195000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	6195000	USD
CY2019Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	93000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2515000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1766000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1365000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	432000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	940111000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	676334000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	5269000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	5269000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4072000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1256000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1286000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	294000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	688511000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	6195000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	5269000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22348000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15284000	USD
CY2019Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-288000	USD
CY2018Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-351000	USD
CY2019Q1	mmsi	Operating Lease Rightof Use Asset Amortization OperatingLeaseRightofUseAssetAmortization	2964000	USD
CY2019Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2018Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	57000	USD
CY2019Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	25000	USD
CY2018Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	USD
CY2019Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	35000	USD
CY2018Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	36000	USD
CY2019Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	201000	USD
CY2018Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	201000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1766000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1256000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11557000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13166000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-1070000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-898000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1340000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5388000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-19000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1223000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	53000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	72000	USD
CY2019Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	442000	USD
CY2018Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	205000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2092000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	491000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-878000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	8409000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3450000	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2395000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-879000	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-480000	USD
CY2019Q1	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	1261000	USD
CY2018Q1	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	3000	USD
CY2019Q1	mmsi	Increase Decreasein Operating Lease Liability IncreaseDecreaseinOperatingLeaseLiability	-3054000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1148000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-337000	USD
CY2019Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	7310000	USD
CY2018Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	2666000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13505000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7935000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18255000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16239000	USD
CY2019Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	853000	USD
CY2018Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	885000	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3000	USD
CY2018Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3000	USD
CY2019Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1942000	USD
CY2018Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	100195000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21047000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-117316000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1733000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1511000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	43119000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	256971000	USD
CY2019Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	54119000	USD
CY2018Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	148971000	USD
CY2019Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-554000	USD
CY2018Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-15000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9821000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	109496000	USD
CY2019Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-474000	USD
CY2018Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1720000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-17837000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1835000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67359000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32336000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49522000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34171000	USD
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet	2721000	USD
CY2018Q1	us-gaap	Interest Paid Net InterestPaidNet	2383000	USD
CY2019Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1934000	USD
CY2018Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1810000	USD
CY2019Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4588000	USD
CY2018Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1752000	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1162000	USD
CY2019Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	117112000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	117703000	USD
CY2019Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	20192000	USD
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	14380000	USD
CY2019Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	61618000	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	65453000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	198922000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	197536000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1766000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1256000	USD
CY2019Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	32800000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	909603	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	492002	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0263
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.3432
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6195000	USD
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54917000	shares
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1573000	shares
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	6195000	USD
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56490000	shares
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	976000	shares
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5269000	USD
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50277000	shares
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2018Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1633000	shares
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	5269000	USD
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51910000	shares
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	184000	shares
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	203035000	USD
CY2018Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	222440000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	5269000	USD
CY2018Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-2050000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2018Q1	us-gaap	Business Acquisition Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax Per Share Basic BusinessAcquisitionProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTaxPerShareBasic	-0.04
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
CY2018Q1	us-gaap	Business Acquisition Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax Per Share Diluted BusinessAcquisitionProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTaxPerShareDiluted	-0.04
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	238349000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	203035000	USD
CY2019Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	238349000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	203035000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	9523000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	8781000	USD
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2677000	USD
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2422000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	651000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1090000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	6195000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	5269000	USD
CY2019Q1	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	Recently Issued Financial Accounting Standards.<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recently Adopted</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-02, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842) </span><span style="font-family:inherit;font-size:10pt;">("ASC 842"), which requires lessees to recognize right-of-use ("ROU") assets and related lease liabilities on the balance sheet for all leases greater than one year in duration. We adopted ASC 842 on January 1, 2019 using a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The modified retrospective approach did not require any transition accounting for leases that expired before the earliest comparative period presented. The adoption of this standard resulted in the recording of ROU assets and lease liabilities for all of our lease agreements with original terms of greater than one year. The adoption of ASC 842 did not have a significant impact on our consolidated statements of operations or cash flows. See Note 14 for the required disclosures relating to our lease agreements. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2018, the FASB issued ASU 2018-07, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting</span><span style="font-family:inherit;font-size:10pt;">, which simplifies the accounting for nonemployee share-based payment transactions by expanding the scope of ASC Topic 718, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Stock Compensation</span><span style="font-family:inherit;font-size:10pt;">, to include share-based payment transactions for acquiring goods and services from nonemployees. Under the new standard, most of the guidance on stock compensation payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. This standard became effective for us on January 1, 2019. The adoption of this standard did not have a material impact on our consolidated financial statements.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2018, the FASB issued ASU 2018-02, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income,</span><span style="font-family:inherit;font-size:10pt;"> which allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from U.S. federal tax legislation commonly referred to as the Tax Cuts and Jobs Act, which was enacted in December 2017 (the "2017 Tax Act"). ASU 2018-02 became effective for us on January 1, 2019. The adoption of this standard did not have a material impact on our consolidated financial statements.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2017, the FASB issued ASU 2017-12, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities</span><span style="font-family:inherit;font-size:10pt;">, which expands and refines hedge accounting for both financial and non-financial risk components, aligns the recognition and presentation of the effects of hedging instruments and hedge items in the financial statements, and includes certain targeted improvements to ease the application of current guidance related to the assessment of hedge effectiveness. ASU 2017-12 became effective for us on January 1, 2019. The adoption of this standard did not have a material impact on our consolidated financial statements.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>We do not believe any other issued and not yet effective accounting standards will be relevant to our consolidated financial statements.
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1100000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	651000	USD
CY2019Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.095
CY2018Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.171
CY2019Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	7000000	USD
CY2018Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	7000000	USD
CY2019Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	313000	USD
CY2018Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	348000	USD
CY2019Q1	us-gaap	Long Term Debt LongTermDebt	384187000	USD
CY2018Q4	us-gaap	Long Term Debt LongTermDebt	395152000	USD
CY2019Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	22000000	USD
CY2018Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	22000000	USD
CY2019Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	362187000	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	373152000	USD
CY2019Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	7000000.0	USD
CY2019Q1	us-gaap	Short Term Debt Percentage Bearing Variable Interest Rate ShortTermDebtPercentageBearingVariableInterestRate	0.0343
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	18250000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	17500000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	348750000	USD
CY2019Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	384500000	USD
CY2019Q1	mmsi	Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Tax AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesTax	-1100000	USD
CY2018Q4	mmsi	Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Tax AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesTax	-1500000	USD
CY2019Q1	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	211000	USD
CY2018Q1	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	57000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	335433000	USD
CY2019Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-413000	USD
CY2019Q1	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	69000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	334951000	USD
CY2019Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	8300000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	129573000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	52469000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	77104000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	128702000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	49136000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	79566000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14800000	USD
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8500000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	44351000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	56238000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	48864000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	47398000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	46136000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P30Y
CY2019Q1	mmsi	Lessee Operating Lease Termination Period LesseeOperatingLeaseTerminationPeriod	P1Y
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	80453000	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11825000	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	72243000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	84068000	USD
CY2015Q4	us-gaap	Sale Leaseback Transaction Amount Due Under Financing Arrangement SaleLeasebackTransactionAmountDueUnderFinancingArrangement	2000000.0	USD
CY2018Q4	us-gaap	Sale Leaseback Transaction Deferred Gain Net SaleLeasebackTransactionDeferredGainNet	93000	USD
CY2019Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	3827000	USD
CY2019Q1	us-gaap	Sublease Income SubleaseIncome	146000	USD
CY2019Q1	us-gaap	Lease Cost LeaseCost	3681000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	3713000	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1162000	USD
CY2019Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.033
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	10380000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	12251000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	11109000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	8822000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	7026000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	53203000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	102791000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	18723000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	84068000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	13421000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	11319000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	9995000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	8053000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	6953000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	52754000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	102495000	USD

Files In Submission

Name	View Source	Status
0000856982-19-000049-index-headers.html	Edgar Link	pending
0000856982-19-000049-index.html	Edgar Link	pending
0000856982-19-000049.txt	Edgar Link	pending
0000856982-19-000049-xbrl.zip	Edgar Link	pending
a2017mmsilogoaa19.jpg	Edgar Link	pending
a2019executivebonuspla.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mmsi-20190331.xsd	Edgar Link	pending
mmsi-20190331_cal.xml	Edgar Link	unprocessable
mmsi-20190331_def.xml	Edgar Link	unprocessable
mmsi-20190331_lab.xml	Edgar Link	unprocessable
mmsi-20190331_pre.xml	Edgar Link	unprocessable
mmsi-3312019x10q.htm	Edgar Link	pending
mmsi-3312019x10qxex311.htm	Edgar Link	pending
mmsi-3312019x10qxex312.htm	Edgar Link	pending
mmsi-3312019x10qxex321.htm	Edgar Link	pending
mmsi-3312019x10qxex322.htm	Edgar Link	pending
mmsi-3312019x10q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vascularinsight-ex103.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MMSI
MERIT MEDICAL SYSTEMS INC Stock $mmsi

2019 Q1 Form 10-Q Financial Statement

#000085698219000049 Filed on May 03, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MMSI MERIT MEDICAL SYSTEMS INC Stock $mmsi

2019 Q1 Form 10-Q Financial Statement

#000085698219000049 Filed on May 03, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MMSI
MERIT MEDICAL SYSTEMS INC Stock $mmsi